In a recent trial, a new melanoma vaccine, mRNA-4157 (V940), when taken in combination with Keytruda (pembrolizumab), was found to be effective in battling the deadly skin cancer. People with advanced melanomas who received the vaccine plus Merck’s cancer drug...
Skip Therapeutics (“Skip”), developer of computational platform for design of Antisense Oligonucleotide (ASO) based therapies and Sheba Medical Center (“Sheba”), one of the leading medical centers in the world, announced today that they have...
Nonprofit standards organization, U.S. Pharmacopeia (USP), has given a talk as part of efforts to raise awareness of its standards for biologics including mAbs and vaccines. USP, which aims to build trust in medicines through public quality standards, says that many...
High-throughput synthesis and screening of biodegradable cyclic ionizable lipids synthesized by Ugi-3CR. a, General reaction scheme of Ugi-3CR (top); structures of the three components of the ionizable lipids (cyclic amine head group, isocyanide/isocyano acetate...
